Psychological stress and vitamins

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 2, 2011, Pages 163-168

  Conti, Chiara M ^a   Fulcheri, M ^a   Anogeianaki, A ^b   Maccauro, G ^c   Tete S ^a   Salini, V ^a   Tripodi, D ^a   Toniato, E ^a   Caraffa, A ^d   Antinolfi, P ^d   Galzio, R ^e   Neri, G ^a   Pandolfi, F ^c   Doyle, R ^f  

^a UNIVERSITY OF CHIETI   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Stress; Vitamins

Indexed keywords

VITAMIN;

ANTIOXIDANT ACTIVITY; EATING HABIT; HUMAN; MALNUTRITION; MENTAL STRESS; NEUROPROTECTION; REVIEW; VITAMIN DEFICIENCY; VITAMIN INTAKE; EDITORIAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

AVITAMINOSIS; HUMANS; IMMUNE TOLERANCE; MALNUTRITION; NEOPLASMS; STRESS, PSYCHOLOGICAL; VITAMINS;

EID: 80052902592     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Kennedy DO, Veasey R, Watson A, Dodd F, Jones E, Maggini S, Haskell CF. Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology (Berl) 2010; 211:55-68.
2. Preetha SP, Devaraj H. Role of sulphated polysaccharides from Sargassum wightii in the control of diet-induced hyperlipidemia and associated inflammatory complications in rats. Eur J Inflamm 2010; 8:23-30.
3. Avanzini MA, Maccario R, Belloni C, et al. B lymphocyte subsets and their functional activity in the early months of life. Int J Immunopathol Pharmacol 2010; 23:247-54.
4. Schubert C, Schüssler G. Psychoneuroimmunology: an update. Z Psychosom Med Psychother 2009; 55:3-26.
5. Cantarini L, Rigante D, Lucherini OM, et al. Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature. Int J Immunopathol Pharmacol 2010; 23:701-7.
6. Migliore A, Bizzi E, Massafra U, Vacca F, Martin Martin LS, Ferlito C, Podestà E, Granata M, Laganà B. Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study). Int J Immunopathol Pharmacol 2010; 23:783-90.
7. Vatrella A, Perna F, Pelaia G, Parrella R, Maselli R, Marsico SA, Calabrese C. T cell activation state in the induced sputum of asthmatics treated with budesonide. Int J Immunopathol Pharmacol 2010; 23:745-53.
8. Freeman MP, Helgason C, Hill RA. Selected integrative medicine treatments for depression: considerations for women. J Am Med Womens Assoc 2004; 59:216-24.
9. Brazzelli V, Grasso V, Fornara L, Moggio E, Gamba G, Villani S, Borroni G. Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity. Int J Immunopathol Pharmacol 2010; 23:911-16.
10. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009; 34:4-20.
11. Yasuda A, Inoue K-i, Sanbongi C, Yanagisawa R, Ichinose T, Yoshikawa T, Takano H. Dietary supplementation with fructooligosaccharides attenuates airway inflammation related to house dust mite allergen in mice. Int J Immunopathol Pharmacol 2010; 23:727-35.
12. Castellani ML, Felaco P, Galzio RJ, et al. IL-31 a TH2 cytokine involved in immunity and inflammation. Int J Immunopathol Pharmacol 2010; 23:709-13.
13. Richardson VJ. Divergent and synergistic regulation of matrix metalloprotease production by cytokines in combination with C-C chemokines. Int J Immunopathol Pharmacol 2010; 23:715-26.
14. Bertone-Johnson ER. Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev 2009; 67:481-92.
15. Hossein-Nezhad A, Khoshniat Nikoo M, Mirzaei K, Mokhtarei F, Aghaei Meybodi HR. Comparison of the bone turn-over markers in patients with multiple sclerosis and healthy control subjects. Eur J Inflamm 2010; 8:67-73.
16. Galliera E, Locati M, Mantovani A, Corsi MM. Chemokine system: new inflammatory markers on the horizon. Eur J Inflamm 2010; 8:1-6.
17. McGrath J. Is it time to trial vitamin D supplements for the prevention of schizophrenia? Acta Psychiatr Scand 2010; 121:321-4.
18. Ciprandi G, Castellazzi AM, Fenoglio D, Battaglia F, Marseglia G. Peripheral Th-17 cells in children with allergic rhinitis: preliminary report. Int J Immunopathol Pharmacol 2010; 23:379-82.
19. Franchi S, Sacerdote P, Moretti S, Gerra G, Leccese V, Tallone MV, Panerai AE, Somaini L. The effects of aleoholism pharmacotherapy on immune responses in alcohol-dependent patients. Int J Immunopathol Pharmacol 2010; 23:847-55.
20. Esposito M, Giunta A, Mazzotta A, Babino G, Talamonti M, Chimenti MS, Chimenti S. Continuous treatment of plaque-type psoriasis with etanercept: an observational long-term experience. Int J Immunopathol Pharmacol 2010; 23:503-9.
21. Zhang G-H, Liu Y-F, Hu H-Y. Preparation and cytotoxicity effect of anti-hepatocellular carcinoma SCFV immunoliposome on hepatocarcinoma cell in vitro. Eur J Inflamm 2010; 8:75-82.
22. Obrenovich ME, Li Y, Parvathaneni K, Yendluri BB, Palacios HH, Leszek J, Aliev G. Antioxidants in health, disease and aging. CNS Neurol Disord Drug Targets 2011; 10:192-207.
23. Duse M, Iacobini M, Leonardi L, Smacchia P, Antonetti L, Giancane G. Transient hypogammaglobulinemia of infancy: intravenous immunoglobulin as first line therapy. Int J Immunopathol Pharmacol 2010; 23:349-53.
24. Ciprandi G, De Amici M, Tosca MA, Marseglia G. Immunoglobulin production pattern in allergic and non-allergic subjects. Eur J Inflamm 2010; 8:193-99.
25. Wei QJ, Wei CN, Harada K, Minamoto K, Okamoto Y, Otsuka M, Ueda A. Evaluation of allergenicity of constituents of myoga using the murine local lymph node assay. Int J Immunopathol Pharmacol 2010; 23:463-70.
26. Garavaglia MC, Altomare G. Etanercept therapy in patients with psoriasis and concomitant HCV infection. Int J Immunopathol Pharmacol 2010; 23:965-9.
27. Shekhawat N, Vijayvergia R. Investigation of anti-inflammatory, analgesic and antipyretic properties of Madhuca indica Gmel. Eur J Inflamm 2010; 8:165-71.
28. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9:46-56. (Pubitemid 350295688)
29. Ursini F, Succurro E, Grembiale A, Rudi S, Grembiale RD, Arturi F. Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab. Int J Immunopathol Pharmacol 2010; 23:961-3.
30. Neri G, Citraro L, Martinotti S, Toniato E, Castriotta A, De Rosa M, Filograna Pignatelli G. The role of atypical microorganisms in chronic oropharyngeal phlogosis. Eur J Inflamm 2010; 8:201-10.
31. Symeonidou I, Pappa S, Kourelis A, Anogeianaki A, Frydas I, Karagouni E, Hatzistilianou M. Microarray analysis of NF-κB signaling pathways in PBMC of mice infected by Trichinella spiralis. Int J Immunopathol Pharmacol 2010; 23:821-31.
32. Profumo E, Buttari B, Alessandri C, Conti F, Capoano R, Valesini G, Salvati B, Riganò R. Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques. Int J Immunopathol Pharmacol 2010; 23:73-80.
33. Chiappini E, Berti L, Bonsignori F, Azzari C, Galli L, de Martino M. CD4+ and CD4-CD1D-restricted natural killer T cells in perinatally HIV-1 infected children receiving highly active antiretroviral therapy. Int J Immunopathol Pharmacol 2010; 23:665-75.
34. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71:171-86
35. Aureli A, Del Beato T, Sebastiani P, Marimpietri A, Melillo CV, Sechi E, Di Loreto S. Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms. Int J Immunopathol Pharmacol 2010; 23:873-80.
36. Trikaliotis C, Soulountsi V, Tsorlini H, et al. Epidemiological study and classification of ICU infections, using the carrier state criterion. Eur J Inflamm 2010; 8:181-88.
37. Marchisio P, Esposito S, Bianchini S, Desantis C, Galeone C, Nazzari E, Pignataro L, Principi N. Effectiveness of a propolis and zinc solution in preventing acute otitis media in children with a history of recurrent acute otitis media. Int J Immunopathol Pharmacol 2010; 23:567-75.
38. Janssen DG, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol 2010; 25:201-15.
39. Cacciapaglia F, Spadaccio C, Gregorj C, et al. Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells. Int J Immunopathol Pharmacol 2010; 23:535-42.
40. Goshen I, Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 2009; 30:30-45.
41. Galli E, Ciucci A, Cersosimo S, Pagnini C, Avitabile S, Mancino G, Delle Fave G, Corleto VD. Eczema and food allergy in an Italian pediatric cohort: no association with TLR-2 and TLR-4 polymorphisms. Int J Immunopathol Pharmacol 2010; 23:671-76.
42. Carlesimo M, Mari E, Arcese A, De Angelis F, Palese E, Abruzzese C, De Marco G, Cattaruzza MS, G Camplone. Safety and efficacy of calcium folinate in psoriasis: an observational study. Int J Immunopathol Pharmacol 2010; 23:649-53.
43. Johnstone SE, Baylin SB. Stress and the epigenetic landscape: a link to the pathobiology of human diseases? Nat Rev Genet 2010; 11:806-12.
44. Di Lorenzo G, Imbimbo M, Leopardo D, Marciano R, Federico P, Buonerba C, Salvatore B, Marinelli A, Calmieri G. A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient. Int J Immunopathol Pharmacol 2010; 23:951-54.
45. Bocchino M, Matarese A, Bellofiore B, Giacomelli P, Russo A, Signoriello G, Galati D, Sanduzzi A. Usefulness of IFN-gamma release assays in clinical management of difficult TB cases:evidence from clinical practice. Eur J Inflamm 2010; 8:43-47.
46. Sharma JN. Activation of the bradykinin system by angiotensin-converting enzyme inhibitors. Eur J Inflamm 2010; 8:55-61.
47. Craddock D, Thomas A. Cytokines and late-life depression. Essent Psychopharmacol 2006; 7:42-52.
48. Fernandez TD, Torres MJ, Lopez S, Antunez C, Gomez E, Del Prado MF, Canto G, Blanca M, Mayorga C. Role of effector cells (CCR7-CD27) and effector-memory cells (CCR7-CD27+) in drug-induced maculopapular exanthema. Int J Immunopathol Pharmacol 2010; 23:437-47.
49. Vogel T, Wolters HH, Hölzen J, Schmidt HH, August C, Dahrenmöller C, Senninger N, Brockmann JG. Rituximab rescue therapy for refractory early acute rejection after liver transplantation. Eur J Inflamm 2010; 8:125-29.
50. Shaik-Dasthagirisaheb YB, Castellani ML, Tripodi D, et al. PGD2, IL-1-family members and mast cells. Eur J Inflamm 2010; 8:137-42.
51. Soczynska JK, Kennedy SH, Goldstein BI, Lachowski A, Woldeyohannes HO, McIntyre RS. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicology 2009; 30:497-521.
52. Castanon-Cervantes O, Wu M, Ehlen JC, et al. Dysregulation of inflammatory responses by chronic circadian disruption. J Immunol 2010; 185:5796-805.
53. Marogna M, Colombo F, Cerra C, Bruno M, Massolo A, Canonica GW, Falagiani P, Passalacqua G. The clinical efficacy of a sublingual monomelic allergoid at different maintenance doses: a randomized controlled trial. Int J Immunopathol Pharmacol 2010; 23:937-45.
54. Pollice R, Bianchini V, Conti CM, Mazza M, Roncone R, Casacchia M. Cognitive impairment and perceived stress in schizophrenic inpatients with post-traumatic stress disorder. Eur J Inflamm 2010; 8:211-19.
55. Miüller N, Schwarz MJ. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm 2007; 72(S):269-80.
56. Hurlock EC 4th. Interferons: potential roles in affect. Med Hypotheses 2001; 56:558-66.
57. Clauss M, Schaper W. Vascular endothelial growth factor: A Jack-of-all-trades or a nonspecific stress gene? Circ Res 2000; 86:251-2. (Pubitemid 30108815)
58. Herberth G, Daegelmann C, Weber A, et al.: LISAplus Study Group. Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children. Clin Exp Allergy 2006; 36:1408-16. (Pubitemid 44674125)
59. Hossein-Nezhad A, Khoshniat Nikoo M, Mirzaei K, Mokhtarei F, Aghaei Meybodi HR. Comparison of the bone turn-over markers in patients with multiple sclerosis and healthy control subjects. Eur J Inflamm 2010; 8:67-73.
60. Sun J, Ramnath RD, Zhi L, Tamizhselvi R, Bhatia M. Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am J Physiol Cell Physiol 2008; 294:C1586-96.
61. Pham TNQ, Rahman P, Richardson VJ. Divergent effects of infliximab and anakinra therapies on macrophage phenotype from patients with refractory rheumatoid arthritis. Int J Immunopathol Pharmacol 2010; 23:491-501.
62. Ciprandi G, Fenoglio D, Ferrera F, De Amici M, Marseglia G. ELISPOT and ELISA assessment of interferon-gamma after sublingual immunotherapy. Eur J Inflamm 2010; 8:31-35.
63. Amanti A, Potalivo G, Pelosi F, Rende R, Cerulli G. Randomized prospective study on the use of Eufiss in the prevention of infections in patients treated with external fixation. Eur J Inflamm 2010; 8:189-92.
64. Palumbo P, Melchiorre E, La Torre C, et al. Effects of phosphatidylcholine and sodium deoxycholate on human primary adipocytes and fresh human adipose tissue. Int J Immunopathol Pharmacol 2010; 23:481-89.
65. Boucher W, Kempuraj D, Michaelian M, Theoharides TC. Corticotropin- releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor. BJU Int 2010; 106:1394-9.